Lactobacillus reuteri DSM 17938 and Improved Treatment Success

• Probiotics for Irritable Bowel Syndrome: Clinical Data in Children.

  • 2016-07-01
  • Systematic Review
  • Journal of pediatric gastroenterology and nutrition 63
  • • Eleonora Giannetti
    • Annamaria Staiano

  • PubMed: 27380595
  • DOI: 10.1097/mpg.0000000000001220

  1 Insight on

  • Improved Treatment Success

  • High evidence
  • Clinical

  A meta-analysis including 9 trials which tested different probiotics as a treatment for Functional Gastrointestinal Disorders (FGIDs) in children and adolescents concluded that Lactobacillus GG, Lactobacillus reuteri DSM 17938 and VSL#3 significantly increased treatment success.

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes